SG10201503504VA - Novel Antimicrobial Compounds And Uses Thereof - Google Patents

Novel Antimicrobial Compounds And Uses Thereof

Info

Publication number
SG10201503504VA
SG10201503504VA SG10201503504VA SG10201503504VA SG10201503504VA SG 10201503504V A SG10201503504V A SG 10201503504VA SG 10201503504V A SG10201503504V A SG 10201503504VA SG 10201503504V A SG10201503504V A SG 10201503504VA SG 10201503504V A SG10201503504V A SG 10201503504VA
Authority
SG
Singapore
Prior art keywords
antimicrobial compounds
novel antimicrobial
novel
compounds
antimicrobial
Prior art date
Application number
SG10201503504VA
Inventor
Lianhui Zhang
Yinyue Deng
Jien Wu
Original Assignee
Agency Science Tech & Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agency Science Tech & Res filed Critical Agency Science Tech & Res
Publication of SG10201503504VA publication Critical patent/SG10201503504VA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/02Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
    • C07C57/03Monocarboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005Antimicrobial preparations
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/347Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups
    • C07C51/377Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups by splitting-off hydrogen or functional groups; by hydrogenolysis of functional groups
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88Lyases (4.)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/90Isomerases (5.)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • C12P7/64Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
    • C12P7/6409Fatty acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • C12P7/64Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
    • C12P7/6409Fatty acids
    • C12P7/6427Polyunsaturated fatty acids [PUFA], i.e. having two or more double bonds in their backbone
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SG10201503504VA 2010-05-14 2011-05-12 Novel Antimicrobial Compounds And Uses Thereof SG10201503504VA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US33472710P 2010-05-14 2010-05-14

Publications (1)

Publication Number Publication Date
SG10201503504VA true SG10201503504VA (en) 2015-06-29

Family

ID=44914590

Family Applications (2)

Application Number Title Priority Date Filing Date
SG10201503504VA SG10201503504VA (en) 2010-05-14 2011-05-12 Novel Antimicrobial Compounds And Uses Thereof
SG2012083242A SG185528A1 (en) 2010-05-14 2011-05-12 Novel antimicrobial compounds and uses thereof

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG2012083242A SG185528A1 (en) 2010-05-14 2011-05-12 Novel antimicrobial compounds and uses thereof

Country Status (4)

Country Link
US (2) US8785680B2 (en)
EP (2) EP3354635A1 (en)
SG (2) SG10201503504VA (en)
WO (1) WO2011142724A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE112008001301T5 (en) 2007-05-14 2010-04-29 Reserach Foundation Of State University Of New York Induction of a physiological dispersion response in bacterial cells in a biofilm
KR101749687B1 (en) 2016-04-25 2017-06-21 경북대학교 산학협력단 Antibacterial agent comprising 7,10-epoxy-octadeca-7,9-dienoic acid
KR101792239B1 (en) 2016-11-01 2017-10-31 경북대학교 산학협력단 Antibacterial agent comprising 7,10-epoxy-octadeca-7,9-dienoic acid and antibiotics
US10695314B2 (en) 2016-04-25 2020-06-30 Kyungpook National University Industry-Academic Cooperation Foundation Antimicrobial composition containing 7,10-epoxyoctadeca-7,9-dienoic acid as active ingredient
CN107417520A (en) * 2017-05-12 2017-12-01 华南农业大学 A kind of Burkholderia cepacia antimicrobial compound and preparation method and application
CN108911969B (en) * 2018-08-02 2021-06-22 重庆市中药研究院 Compound for preventing and treating citrus canker and application thereof
US11197824B2 (en) * 2020-01-16 2021-12-14 David Changaris Solution and method for reducing the virulence of viruses, bacteria,yeasts, or fungus
US20230142090A1 (en) * 2020-04-01 2023-05-11 Cornell University Compositions and methods for inhibiting vibrio infection
CN113402385B (en) * 2021-07-20 2022-08-26 湖北大学 Antibacterial compound derived from fungal metabolite, preparation method and application

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3146256A (en) 1957-10-10 1964-08-25 Montedison Spa Preparation of alpha-beta, delta-epsilon unsaturated carboxylic derivatives
US3236879A (en) 1957-10-10 1966-02-22 Montedison Spa Preparation of alpha-beta, deltaepsilon unsaturated carboxylic acids and esters
DE1109671B (en) 1958-10-17 1961-06-29 Basf Ag Process for the production of ª ‡, ª ‰ -unsaturated carboxylic acid esters or the free acids
NL129288C (en) 1965-02-04
US4021461A (en) 1971-11-22 1977-05-03 Zoecon Corporation Aliphatic hydrocarbon 2,4-dienoic acids, esters and derivatives thereof
DE3347128A1 (en) * 1983-12-22 1985-07-11 Schering AG, 1000 Berlin und 4709 Bergkamen 9-HALOGEN- (DELTA) (ARROW HIGH) 2 (ARROW HIGH) -PROSTAGLAND IN DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS MEDICINAL PRODUCTS
US4575512A (en) * 1984-11-01 1986-03-11 E. R. Squibb & Sons, Inc. 7-Oxabicycloheptane substituted oxa prostaglandin analogs and their anti-thrombotic compositions and methods
WO2003039529A1 (en) 2001-11-07 2003-05-15 4Sc A.G. Selective antibacterial agents
US7135575B2 (en) * 2003-03-03 2006-11-14 Array Biopharma, Inc. P38 inhibitors and methods of use thereof
EP1763528B1 (en) * 2004-07-05 2008-11-26 Astellas Pharma Inc. Pyrazolopyridine derivatives

Also Published As

Publication number Publication date
US20140256812A1 (en) 2014-09-11
EP2569273B1 (en) 2018-04-04
EP2569273A4 (en) 2014-03-26
SG185528A1 (en) 2012-12-28
US20130131172A1 (en) 2013-05-23
EP3354635A1 (en) 2018-08-01
US9012505B2 (en) 2015-04-21
US8785680B2 (en) 2014-07-22
WO2011142724A1 (en) 2011-11-17
EP2569273A1 (en) 2013-03-20

Similar Documents

Publication Publication Date Title
ZA201301301B (en) Antimicrobial formulation
EP2549993A4 (en) Antimicrobial compositions
EP2635285A4 (en) Heteroaryl compounds and uses thereof
EP2563956A4 (en) Antimicrobial substrate
HRP20160922T1 (en) Oligopeptidic compounds and uses thereof
ZA201205516B (en) Antimicrobial compounds and fibers thereof
SG10201503504VA (en) Novel Antimicrobial Compounds And Uses Thereof
EP2582246A4 (en) Biocidal composition
ZA201303773B (en) Compounds and their use
EP2575453A4 (en) Oligo-benzamide compounds and their use
SI2654440T1 (en) Microbicidal composition
EP2627172A4 (en) An antimicrobial composition
EP2753341A4 (en) Antimicrobial compositions and uses thereof
EP2615094A4 (en) Sesterterpene compounds and use thereof
GB201002673D0 (en) Antimicrobial agent
GB201022132D0 (en) Anti-microbial composition
GB201001632D0 (en) Antimicrobial compounds
GB201015592D0 (en) Antimicrobial materials
GB201014319D0 (en) Compounds and uses thereof
GB201021626D0 (en) Novel antimicrobial compounds
GB201005921D0 (en) Antimicrobial compositions and uses
EP2567956A4 (en) Novel prenylarene compound and use thereof
AU2011904886A0 (en) Antimicrobial compounds and uses thereof
GB201111128D0 (en) Antimicrobial compositions
GB201013150D0 (en) Antimicrobial compositions